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Although dried blood spot (DBS) sampling is increasingly receiving interest as a potential 
alternative to traditional blood sampling, the impact of hematocrit (Hct) on DBS results is 
limiting its final breakthrough in routine bioanalysis. To predict the Hct of a given DBS, 
potassium (K
+
) proved to be a reliable marker. The aim of this study was to evaluate whether 
application of an algorithm, based upon predicted Hct or K
+ 
concentrations as such, allowed 
to correct for the Hct bias. Using validated LC-MS/MS methods, caffeine, chosen as a model 
compound, was determined in whole blood and corresponding DBS samples with a broad Hct 
range (0.18 – 0.47). A reference subset (n = 50) was used to generate an algorithm based on 
K
+
 concentrations in DBS. Application of the developed algorithm on an independent test set 
(n = 50) alleviated the assay bias, especially at lower Hct values. Before correction, 
differences between DBS and whole blood concentrations ranged from -29.1 to 21.1 %. The 
mean difference, as obtained by Bland-Altman comparison, was -6.6 % (95 % CI; [-9.7 – -3.4 
%]). After application of the algorithm, differences between corrected and whole blood 
concentrations lay between -19.9 and 13.9 % with a mean difference of -2.1 % (95 % CI; [-4.5 
– 0.3 %]). The same algorithm was applied to a separate compound, paraxanthine, which was 
determined in 103 samples (Hct range 0.17 – 0.47), yielding similar results. In conclusion, a 
K
+
-based algorithm allows to correct for the Hct bias in the quantitative analysis of caffeine 
and its metabolite paraxanthine. 






In recent years, dried blood spot (DBS) sampling has increasingly received interest as an 
alternative sampling strategy. However, despite the numerous DBS-based methods that have 
been developed and the many advantages associated with this sampling technique [1-2], its 
implementation in routine quantitative bioanalysis has to a great extent been limited by the 
hematocrit (Hct) issue [3]. This Hct issue is a problem that is both analytical and 
physiological in nature. The analytical facet comprises the impact of Hct on blood viscosity 
and, hence, the spreading of the blood on filter paper. Consequently, fixed size punches, taken 
from DBS with varying Hct values, will contain different amounts of blood. This facet also 
encompasses the influence of Hct on sample homogeneity, extraction efficiency and matrix 
effect [4]. The physiological facet of the Hct issue, on the other hand, relates to the influence 
of the Hct on the blood-to-plasma concentration ratio of an analyte. The latter is of key 
importance when DBS results are to be compared with established plasma- or serum-based 
reference intervals or therapeutic ranges [5].   
 
As strongly deviating Hct values may have a significant impact on method accuracy and 
precision, as well as on the interpretation of DBS results, multiple strategies have been 
suggested to overcome this obstacle. These include analysis of whole, volumetrically applied 
DBS, the use of dried plasma spots instead of DBS or spotting on special filter substrates that 
are less prone to differential spreading of blood [3,6]. On the other hand, when DBS are 
prepared in a non-volumetric way, followed by analysis of partial punches, it is vital to define 
a Hct interval for every analyte in which method accuracy and precision are still adequate. 
Additionally, to minimize the Hct impact, calibration curves should be centered around a Hct 
value close to the median of the population of interest. However, even when such a Hct 
interval has been established, one still needs to confirm whether or not the Hct of a given 
DBS actually lies within this interval. To this end, a reliable marker is required that allows to 
predict the Hct of the blood used to prepare a given DBS. We previously demonstrated that 
potassium (K
+
), an endogenous compound that correlates with the amount of red blood cells, 
allows to predict the Hct over a wide range  with acceptable accuracy and precision [7]. This 
method was thoroughly validated and application on real patient samples showed a good 
correlation between the estimated Hct (based on the K
+
 content) and the real Hct. However, 
hitherto, it has not been demonstrated if –and how– this Hct prediction may effectively assist 
in overcoming the Hct problem for a given DBS-based analytical method in real practice. 
Therefore, the aim of this study was to evaluate whether application of an algorithm, based 
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upon the predicted Hct or the K
+ 
concentrations as such, could adjust for the Hct-induced bias 
in the quantitative analysis of caffeine. Caffeine was selected as a model drug, since we 
previously observed a Hct effect on the accuracy of measured caffeine concentrations in DBS 
by analyzing quality control samples prepared from spiked blood with a wide Hct range (0.20 
– 0.60) [8]. In this context, we also found that strongly deviating Hct values had no impact on 
matrix effect and recovery, using a similar Hct range (0.19 – 0.63) [9]. Furthermore, given the 
widespread consumption of caffeine-containing food products, a sufficient number of positive 
samples could be obtained without the need to set up a clinical study involving actual 
administration of a probe drug. 
 








N3 and formic acid were purchased 
from Sigma-Aldrich (Sigma-Aldrich, Diegem, Belgium), while KCl was obtained from UCB 
(UCB, Leuven, Belgium). LC-MS grade methanol was purchased from Biosolve (Biosolve, 
Valkenswaard, The Netherlands) and a Synergy
®
 Water Purification System (Merck 
Millipore, Overijse, Belgium) provided ultrapure water. 
2.2 Sample collection 
Venous whole blood samples were obtained from both healthy volunteers (n = 61) and 
hospital patients (n = 117) and collected in Venosafe
®
 4 mL VF-054SHL or 9 mL VF-
109SHL Li-heparin tubes (Terumo, Leuven, Belgium). Prior to blood collection, all healthy 
volunteers (age 24 – 48 years, 44 women and 17 men) were informed and signed informed 
consent. This study was approved by the Ethics Committee of Ghent University Hospital 
(Belgian registration number B670201111655 and B670201214201), which also approved the 
use of aliquots of routinely collected Li-heparin patient blood samples, admitted to the 
Laboratory of Clinical Biology of Ghent University Hospital (B670201319311). Because of 
an opting-out procedure, foreseeing the possibility of comparative analysis on left-over 
samples, no individualized informed consent was needed for the hospital patients. The 
samples were included in this study to obtain blood samples with deviating Hct values.  As 
these were anonymized left-over samples, no additional data concerning age or sex of the 
donors could be traced back. On the day of venous blood sampling, corresponding DBS were 
prepared by spotting 25 µL whole blood on WHA10334885 Whatman 903 filter paper (GE 
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Healthcare, Dassel, Germany). The resulting DBS were air-dried for 2 hours and stored at 
ambient temperature in zip-closure plastic bags, containing two 5-g Minipax
® 
absorbent 
packets as desiccant (Sigma-Aldrich, Diegem, Belgium). Liquid blood samples were stored at  
-20 °C until analysis.   
2.3 Analyses 
Concentrations of caffeine and its major metabolite paraxanthine were determined in whole 
blood and DBS using previously developed and validated methods on a Waters Acquity 
UPLC
®
 system (Waters, Milford, MA, USA) coupled to an AB SCIEX API 4000
™
 triple 
quadrupole mass spectrometer (AB SCIEX, Framingham, MA, USA) [9]. For whole blood 
samples, a protein precipitation was performed by adding 100 µL of methanol, containing 
0.01 % formic acid, to 50 µL of blood after the addition of 10 µL of an internal standard (IS) 
solution. DBS punches (3 mm) were extracted in 70 µL of a methanol/water (80/20, v/v) 
mixture, containing 0.01 % formic acid and the IS. After gentle shaking for 10 minutes, whole 
blood and DBS samples were centrifuged and the resulting supernatants were diluted with 
water, containing 0.01 % formic acid. Further details of the analytical methods are described 
elsewhere [9].  
K
+
 concentrations in DBS extracts were measured by indirect potentiometry, using the ion-
selective electrode of a Roche Cobas 8000 routine chemistry analyzer (Roche Diagnostics, 
Mannheim, Germany), as previously described [7]. K
+
 was extracted from 3-mm DBS 
punches by two-fold addition of 50 µL of a 2.5 mM KCl solution in ultrapure water and 
shaking for 5 minutes. Actual DBS K
+ 
concentrations were obtained by subtracting the value 
in the extraction solution from the measured value. These K
+ 
concentrations allowed to 
predict the approximate Hct of the blood used to prepare the DBS. Direct Hct measurement in 
whole blood was performed on a Sysmex XE-5000 hematology analyzer (Sysmex, Kobe, 
Japan). 
2.4 Data analysis 
Samples in which caffeine was measured were randomly assigned to a reference and test set 
of samples, thereby ensuring that Hct values were similarly distributed in both groups. For the 
reference set, the whole blood/DBS caffeine concentration ratios were plotted against K
+
-
based calculated Hct. A linear regression line was fitted to these data by applying the least 
squares method. The slope and intercept, together with their 95 % confidence intervals (CIs), 
were obtained using the Analysis Toolpack of MS Excel
® 
2013 (Microsoft, Redmond, WA, 
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USA). From the resulting linear model, a Hct-based correction algorithm was derived by a 
simple transformation. As the calculated Hct used to generate the algorithm was based on K
+ 
concentrations measured in DBS, a similar algorithm could be generated using the K
+ 
concentrations as such. The resulting algorithm was applied to the independent test set. To 
further evaluate the usefulness of this approach, the same algorithm that was constructed for 
caffeine was applied to another compound, paraxanthine, which was also determined in 
samples from healthy volunteers and hospital patients.  
To assess the extent of the Hct effect before and after implementation of a correction 
algorithm, the differences (%) between DBS concentrations (uncorrected or corrected) and 
whole blood concentrations were plotted against measured and calculated Hct values for the 
caffeine reference set and against K
+ 
concentrations for the caffeine and paraxanthine test sets. 
Percentage differences were calculated by dividing the difference between DBS and whole 
blood concentrations by the whole blood concentration and multiplying the result by 100. To 
the data of the test sets, linear regression lines were fitted by applying the least squares 
method. Slope, intercept and corresponding 95 % CIs were obtained as described above. 
Additionally, uncorrected and corrected concentrations were compared with corresponding 
whole blood concentrations using Bland-Altman plots, which were generated with Medcalc 
version 12.7.5 (Medcalc Software bvba, Ostend, Belgium).     
 
3 Results and discussion  
Caffeine concentrations above the LLOQ (50 ng/mL) were measured in whole blood and DBS 
samples from 100 subjects, both healthy volunteers and hospital patients, displaying a wide 
Hct range (0.18 – 0.47). Figure 1a shows the Hct distribution in the entire sample set. The 
differences (%) between uncorrected caffeine concentrations in DBS and whole blood, plotted 
against Hct values measured in whole blood for the reference set (n = 50), are shown in 
Figure 2a. Lower DBS concentrations were found at low Hct levels, while higher 
concentrations were measured at high Hct levels, with differences ranging from -29.3 to 25.4 
%. A similar pattern of decreasing uncorrected DBS concentrations with decreasing Hct was 
observed when differences (%) were plotted against calculated Hct values (Figure 2b), 
illustrating the validity of K
+
-based Hct prediction [7].  
The linear regression line fitted to the whole blood/DBS concentration ratios versus the 
calculated Hct for the reference set had a slope of -1.33 (95 % CI; [-1.74 – -0.93]) and an 
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intercept of 1.51 (95 % CI; [1.37 – 1.65]). From this linear relationship, an algorithm to 
correct the caffeine DBS concentrations, taking into account the calculated Hct of the DBS, 
was derived: corrected DBS concentration = uncorrected DBS concentration * ((-1.33 * 
calculated Hct) + 1.51). The impact of applying the developed algorithm can be deducted 
from Figure 2c, showing the differences between corrected DBS concentrations and whole 
blood concentrations plotted against the calculated Hct.  
When whole blood/DBS concentration ratios were directly plotted against K
+ 
concentrations, 
as the latter were used to calculate the Hct, the resulting linear regression line had a slope of -
0.41 (95 % CI; [-0.54 – -0.29]) and an intercept of 1.51 (95 % CI; [1.37 – 1.64]). From these 
data, the following algorithm was derived: corrected concentration = uncorrected DBS 
concentration * ((-0.41 * K
+ 
concentration) + 1.51). However, as this algorithm was based on 
the reference sample set, it is likely to work for this given set of samples. Therefore, the 
algorithm needed to be applied to the remaining samples (n = 50), representing an 
independent test set. The differences (%) between uncorrected DBS caffeine concentrations 
and whole blood caffeine concentrations versus measured K
+ 
concentrations in this test set are 
shown in Figure 3a. Before application of the algorithm, a Hct effect similar to that in the 
reference set was observed, as the regression line of the plotted variables, with K
+
 
concentrations representing a measure of Hct, had a slope of 32.03 (95 % CI; [21.38 – 42.68]) 
and an intercept of -41.05 (95 % CI; [-53.00 – -29.10]). Differences between uncorrected 
caffeine concentrations in DBS and whole blood ranged from -29.1 to 21.1 %. For 14 samples 
(i.e. 28 % of the data set), the difference was beyond ± 15 % limits. After application of the 
developed algorithm (Figure 3b), the regression line had a slope of -3.81 and an intercept of 
2.44. The 95 % CIs of slope and intercept, respectively [-14.59 – 6.97] and [-9.65 – 14.53], 
included the zero-value. The differences between corrected and whole blood concentrations 
ranged from -19.9 to 13.9 %. Now, for only 4 samples (i.e. 8 % of the data set) the differences 
exceeded  ± 15 % limits and none of the calculated concentrations deviated more than 20 % 
from the measured whole blood concentration. These findings were supported by the results 
of Bland-Altman comparisons, which clearly demonstrate the effect of the correction 
algorithm. The mean difference between uncorrected DBS caffeine concentrations and whole 
blood caffeine concentrations was -6.6 % (95 % CI; [-9.7 – -3.4  %]) (Figure 3c), while the 
mean difference between corrected concentrations and whole blood concentrations was -2.1 
% (95 % CI; [-4.5 – 0.3 %]) (Figure 3d). As the latter 95 % CI contained 0, a consistent 
negative bias was no longer observed after correction.  
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Application of the same algorithm to paraxanthine, caffeine’s major metabolite, further 
demonstrated the usefulness of the presented approach. Paraxanthine concentrations above the 
LLOQ could be measured in samples from 103 participants (Hct range 0.17 – 0.47). The Hct 
distribution in this sample set is shown in Figure 1b. The differences (%) between uncorrected 
DBS paraxanthine and whole blood paraxanthine concentrations versus measured K
+ 
concentrations are shown in Figure 4a. Also for this compound, uncorrected DBS 
concentrations were considerably affected by Hct, as the slope of the regression line of the 
plotted variables was 34.83 (95 % CI; [28.33 – 41.33]) and the intercept -45.12 (95 % CI; [-
52.32 – -37.92]). The differences between uncorrected DBS and whole blood paraxanthine 
concentrations ranged from -35.2 to 15.8 %. Application of the algorithm yielded similar 
results as obtained for caffeine (Figure 4b), with the slope of the regression line being 1.58 
and the intercept -4.56. Also here, the 95 % CIs of slope and intercept, respectively [-5.60 – 
8.76] and [-12.51 – 3.39], included the zero-value. Differences between corrected and whole 
blood paraxanthine concentrations lay between -21.3 and 18.8 %. Before correction, the 
difference was beyond the ± 15 % limits for 22 samples (i.e. 21 % of the data set), while this 
was the case for only 8 samples (i.e. 8 % of the data set) after correction. With a single 
exception (-21.3 %), all corrected paraxanthine concentrations were within ± 20 % of the 
concentrations measured in whole blood. Also here, Bland-Altman comparisons supported the 
obtained results. Before correction, the mean difference was -8.2 % (95 % CI; [-10.6 – -5.9 
%]) (Figure 4c). Again, the observed negative bias decreased considerably after correction, as 
the mean difference between corrected and whole blood paraxanthine concentrations was -3.2 
% (95 % CI; [-4.8 – -1.6 %]) (Figure 4d). 
 
4 Conclusion  
Based on the findings described above, we conclude that we are able to correct for the Hct 
bias in the quantitative analysis of caffeine in DBS, using a K
+
-based algorithm. The same 
algorithm, initially designed for caffeine, was applied to a separate compound, paraxanthine, 
yielding similar results. Caffeine and paraxanthine are weakly basic compounds that show 
low binding to plasma or red blood cell proteins [5]. To further support the broader 
applicability of the presented approach, its usefulness should be evaluated for more analytes, 
displaying varying physicochemical properties and binding characteristics, The latter should 
include, amongst others, neutral, acidic and basic compounds, hydrophilic and hydrophobic 
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substances and analytes with different plasma protein binding and blood cell association 
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Fig. 1 Hematocrit (Hct) distribution of blood samples collected from healthy volunteers and 
hospital patients in which caffeine (a) and paraxanthine (b) concentrations were measured 
*Calculated Hct: Hct of the blood used to prepare the DBS, as calculated using the K+ 





Fig. 2 Percentage differences (%) between uncorrected caffeine concentrations in dried blood 
spots (DBS) and whole blood plotted against hematocrit (Hct) measured in whole blood (a), 
against calculated Hct (b) and percentage differences (%) between corrected and whole blood 
caffeine concentrations plotted against calculated Hct (c). Dashed lines indicate ± 15 % 
difference limits, the full line indicates 0 % difference. All data were obtained from a 
reference set of whole blood and DBS samples (n = 50)  
*Calculated Hct: Hct of the blood used to prepare the DBS, as calculated using the K+ 
concentration measured in the DBS [7]; 
 
Measured Hct: Hct directly measured in whole blood 













Fig. 3 Percentage differences (%) between uncorrected caffeine concentrations in dried blood 
spots (DBS) and whole blood (a) and between corrected and whole blood caffeine 
concentrations (b). Differences are plotted against potassium concentrations in DBS, dashed 
lines indicate ± 15 % difference limits and the full line indicates 0 % difference. Bland-
Altman plot for the comparison between uncorrected DBS caffeine concentrations and whole 
blood caffeine concentrations (c) and between corrected and whole blood caffeine 
concentrations (d). The mean differences and the limits of agreement (LoAs) are displayed 
(full lines), together with their 95 % confidence limits (dashed lines). All data were obtained 













Fig. 4 Percentage differences (%) between uncorrected paraxanthine concentrations in dried 
blood spots (DBS) and whole blood (a) and between corrected and whole blood paraxanthine 
concentrations (b). Differences are plotted against potassium concentrations in DBS, dashed 
lines indicate ± 15 % difference limits and the full line indicates 0 % difference. Bland-
Altman plot for the comparison between uncorrected DBS paraxanthine concentrations and 
whole blood paraxanthine concentrations (c) and between corrected and whole blood 
paraxanthine concentrations (d). The mean differences and the limits of agreement (LoAs) are 
displayed (full lines), together with their 95 % confidence limits (dashed lines). All data were 
obtained from a test set of whole blood and DBS samples (n = 103) 
 
